---
schema_version: "secwatch.filing_event.v1"
accession: "0001551306-24-000199"
form_type: "8-K"
ticker: "PGNY"
cik: "0001551306"
company_name: "Progyny, Inc."
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T01:51:47.428828+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Progyny Q3 revenue up 2% to $286.6M, net income falls 34% to $10.4M; cuts FY2024 guidance

## Summary
- Revenue $286.6M (+2% YoY); net income $10.4M ($0.11 diluted EPS) vs $15.9M ($0.16) in Q3 2023.
- Adjusted EBITDA $46.5M (-7.1% YoY); margin 16.2% vs 17.8% a year ago.
- Full-year 2024 revenue guidance lowered to $1.135-1.150B; adjusted EBITDA guidance $189-194M.
- New sales season adds 80+ clients, 1.1M new covered lives; also selected by two health plans as preferred partner.
- Q3 utilization rate lower than expected; members took longer to progress, consuming fewer treatments.

## SEC filing metadata
- accession: 0001551306-24-000199
- form_type: 8-K
- ticker: PGNY
- cik: 0001551306
- company_name: Progyny, Inc.
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1551306/000155130624000199/0001551306-24-000199-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1551306/000155130624000199/pgny-20241112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001551306-24-000199
- JSON: https://secwatch.observer/filing/0001551306-24-000199.json
- Plain text: https://secwatch.observer/filing/0001551306-24-000199.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.